On the morning of August 23, 2022, entrusted by Zeng Bin, Secretary General of Chengdu High-tech Medical Association, Bu Wei, Deputy Director of the Collaborative Innovation Center for Medical-Industrial Integration of Chengdu High-tech Medical Association, together with Hong Tao, Executive General Manager of CITIC Securities Co., Ltd., systematically inspected the Chengdu Biotec Biotechnology Co., Ltd.

After the visit, the three parties had exchanges and discussions on the pipeline and equity structure design before the launch of the new human rabies vaccine. The company's founder Sheng Xiaobin and chairman Liang Zhijie accompanied the visit and attended the meeting.

Sheng Xiaobin, founder of Biotec, introduced: The company is currently committed to using international mainstream strains and cells, using stable and efficient production processes, and no added animal-derived materials throughout the process, to produce vaccine products with higher quality and safety, and the products have competitive advantages. , the future development momentum is good; it will use the platform of the High-tech Medical Association to promote the transformation of scientific and technological achievements.

Hong Tao, executive general manager of CITIC Securities, emphasized that enterprises must seize the opportunities of existing industrial development, make use of various policies and platform resources, solve practical problems for enterprises, and vigorously promote the transformation of scientific and technological achievements.

Bu Wei, deputy director of the Collaborative Innovation Center for Medical-Industrial Integration of Chengdu High-tech Medical Association, said: I hope to take this symposium as an opportunity to further deepen multi-party understanding, integrate industry resources, and help enterprises innovate and transform.

All three parties at the meeting believed that further integration of resources, mutual benefit and win-win situation are needed, and they are jointly committed to promoting the development of the biomedical health industry, and to explore and innovate in order to jointly build a new model of the pharmaceutical ecosystem and promote inclusive development.

At noon on the 23rd, Zeng Bin, Secretary General of Chengdu High-tech Medical Association, and Bu Wei, Deputy Director of the Collaborative Innovation Center for Medical-Industrial Integration, together with Hong Tao, Executive General Manager of CITIC Securities, and a group of four went to Chengdu Huaxi Haiqi Pharmaceutical Technology Co., Ltd., together with Chengdu Huaxi Haiqi Pharmaceutical Technology Co., Ltd. Wang Li, Chairman of the Co., Ltd., Yu Yuan, Deputy General Manager of Haifeng Biology, and Ran Wenping, Secretary-General of Chengdu High-tech Zone Biological Industry Experts Association, had exchanges and discussions on the establishment of service platforms, the introduction of corporate capital and product listing.

In the end, the representatives of the five parties participating in the exchange reached a consensus: all platform resources should join hands to build multiple paths such as information sharing, technological finance and technological exchanges, and enhance all-round services such as industry-university-research cooperation, so as to enhance the core competitiveness of enterprises and promote industry Contribute to the transformation process of scientific and technological achievements.